anonymous
Guest
anonymous
Guest
AZ's annual bloodletting. This time it's CV & Renal's turn in the crosshairs.
Unfortunate but that's the pharma reality and we all know it.
How bad is it turning out to be?
And what kind of spin are they weaving as to plans for the survivors going forward?
Unfortunate but that's the pharma reality and we all know it.
How bad is it turning out to be?
And what kind of spin are they weaving as to plans for the survivors going forward?